Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study

por Gernaat, S. A. M., von Stedingk, H., Hassan, M., Nilsson, H. P., Rodriguez-Wallberg, K. A., Hedayati, E., Rydberg, P.
Publicado 2021